None of these clinical parameters showed a significant correlation with FABP4 expression in tumors except the Elston-Ellis grade (Fig. 4D), which showed a weak but significant correlation with FABP4 H-score (Grade 1: 3.22 ± 4.69; Grade 2: 6.27 ± 10.99; Grade 3: 15.13 ± 28.1) in tumor cells. This evidence concerns the gene FABP4 and neoplasm.